Roger Løvlie

Dopamine D3-receptor gene variant and susceptibility to tardive dyskinesia in schizophrenic patients

Vidar M. Steen, Roger Løvlie, Tom MacEwan et al. · Molecular Psychiatry · 1997 · 242 citations

Medicine, Neuroscience, Psychiatry +14

Ultrarapid metabolizers of debrisoquine: Characterization and PCR‐based detection of alleles with duplication of the <i>CYP2D6</i> gene

Roger Løvlie, Ann K. Daly, Anders Molven et al. · FEBS Letters · 1996 · 195 citations · Full text

Life Sciences, Genetics, Molecular Genetics +14

Identification of genes co‐upregulated with <i>Arc</i> during BDNF‐induced long‐term potentiation in adult rat dentate gyrus <i>in vivo</i>

Karin Wibrand, Elhoucine Messaoudi, Bjarte Håvik et al. · European Journal of Neuroscience · 2006 · 156 citations

Life Sciences, Neurobiology, Neuroscience +16

Antipsychotic drugs activate SREBP-regulated expression of lipid biosynthetic genes in cultured human glioma cells: a novel mechanism of action?

Johan Fernø, Audun Osland Vik‐Mo, Silje Skrede et al. · The Pharmacogenomics Journal · 2005 · 150 citations

Medicine, Biochemistry, Pharmacology +13

Polymorphisms in CYP2D6 duplication-negative individuals with the ultrarapid metabolizer phenotype: a role for the CYP2D6*35 allele in ultrarapid metabolism?

Roger Løvlie, Ann K. Daly, Guri E. Matre et al. · Pharmacogenetics · 2001 · 102 citations

Life Sciences, Genetics, Pharmacology +13